Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn's disease (CD)
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
_256_384.jpg)
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
At the recommended Phase 3 dose of 200 mg vepdegestrant in combination with palbociclib, patients achieved a median progression-free survival of 13.9 months
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Subscribe To Our Newsletter & Stay Updated
